Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol cream versus triamcinolone cream for hand and/or foot eczema
IRCT20150706023081N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of timolol and triamcinolone in atopic dermatitis (AD), hand dermatitis and dermatitis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: modified Total Lesion Symptom Score. Started Mar 2024; status: completed.
02
Drugs
timololtriamcinolone
03
Conditions
atopic dermatitis (AD)hand dermatitisdermatitis
Beyond the preview
Go deeper on IRCT20150706023081N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150706023081N3.